Hamlet BioPharma AB (publ) (XSAT:HAMLET.B)
6.08
+0.10 (1.67%)
At close: Sep 30, 2026
Hamlet BioPharma AB Income Statement
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Other Revenue | 0 | - | 0.21 | - | 2.34 | 9.96 |
Revenue | 0 | - | 0.21 | - | 2.34 | 9.96 |
Revenue Growth | -99.22% | - | - | - | -76.53% | 6.97% |
Gross Profit | 0 | - | 0.21 | - | 2.34 | 9.96 |
Selling, General & Admin | 44.88 | 45.56 | 44.82 | 32.93 | 22.43 | 27.06 |
Other Operating Expenses | 0.14 | 0.1 | 0.05 | 0.02 | -0.05 | 0.01 |
Operating Expenses | 55.23 | 55.84 | 55.33 | 42.56 | 22.88 | 27.08 |
Operating Income | -55.23 | -55.84 | -55.13 | -42.56 | -20.54 | -17.12 |
Interest Expense | -0.02 | - | - | - | - | -0.08 |
Interest & Investment Income | 0.23 | 0.23 | 0.47 | 0.72 | 0.1 | - |
Currency Exchange Gain (Loss) | 0.05 | 0.05 | - | 0.02 | - | - |
Other Non Operating Income (Expenses) | - | -0 | -0 | - | 0 | - |
Pretax Income | -54.96 | -55.56 | -54.65 | -41.82 | -20.44 | -17.2 |
Net Income | -54.96 | -55.56 | -54.65 | -41.82 | -20.44 | -17.2 |
Net Income to Common | -54.96 | -55.56 | -54.65 | -41.82 | -20.44 | -17.2 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | - | 186 | 178 | 168 | 112 | 111 |
Shares Outstanding (Diluted) | - | 186 | 178 | 168 | 112 | 111 |
Shares Change | - | 4.78% | 5.91% | 49.74% | 1.37% | 9.57% |
EPS (Basic) | - | -0.30 | -0.31 | -0.25 | -0.18 | -0.16 |
EPS (Diluted) | - | -0.30 | -0.31 | -0.25 | -0.18 | -0.16 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -46.84 | -44.63 | -38.85 | -36.28 | -29.59 | -20.32 |
Free Cash Flow Per Share | - | -0.24 | -0.22 | -0.22 | -0.26 | -0.18 |
Gross Margin | 100.00% | - | 100.00% | - | 100.00% | 100.00% |
Operating Margin | -3400971.30% | - | -26497.83% | - | -878.36% | -171.87% |
Profit Margin | -3384540.46% | - | -26270.61% | - | -874.19% | -172.63% |
Free Cash Flow Margin | -2884350.49% | - | -18676.37% | - | -1265.39% | -203.95% |
EBITDA | -44.69 | -45.38 | -44.66 | -32.95 | -20.04 | -17.11 |
EBITDA Margin | - | - | - | - | - | -171.78% |
D&A For EBITDA | 10.54 | 10.46 | 10.46 | 9.6 | 0.5 | 0.01 |
EBIT | -55.23 | -55.84 | -55.13 | -42.56 | -20.54 | -17.12 |
EBIT Margin | - | - | - | - | - | -171.87% |
Revenue as Reported | 0.06 | 0.05 | 0.21 | 0.03 | 2.42 | 9.98 |